• Home
  • Resources
  • Education
  • Patient with Stage IB NSCLC, an Oncocyte DetermaRx High-Risk Result and an EGFR Exon 19 Deletion

Patient with Stage IB NSCLC, an Oncocyte DetermaRx High-Risk Result and an EGFR Exon 19 Deletion

The panel discusses stratification for patients with early-stage NSCLC brief presentation and case review for a patient with Stage IB NSCLC, an Oncocyte DetermaRx high-risk result and an EGFR exon 19 del.